Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of YD0293 in Healthy Subjects
Clinical trial NCT07098091 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07098091
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-26
- Primary completion
- 2025-12-31
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.